<DOC>
	<DOCNO>NCT00946907</DOCNO>
	<brief_summary>Treatment pericarditis largely remain empirical due relative lack randomize controlled trial . Nevertheless , recommendation formulate guide management follow-up acute pericarditis . Aspirin NSAID medium high dosage mainstay treatment . Optimal length treatment establish . PERICARDITE French multicentric placebo control double blind randomize trial assess efficacy brief treatment base Aspirin ( 4 day ) versus longer treatment ( 21days ) treat first episode probably idiopathic acute pericarditis . It non inferiority trial . Exclusion criterion : disease know cause pericarditis : ( recent myocardial infarction , autoimmune disease , postpericardiotomy syndrome , connective tissue disease , tuberculosis , neoplastic disease ) . Primary endpoint : 30 day recovery define normalization clinical paraclinical initial abnormality . Secondary endpoint : 6-month recurrence .</brief_summary>
	<brief_title>Benign Acute Pericarditis : Brief Versus Longer Treatment Using Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Pericarditis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>age 18 first episode acute pericarditis chest pain last less 24 hour contraindication aspirin previous history atypical chest pain previous history connective tissue disease , tuberculosis , recent MI , auto immune disease , neoplastic disease , thoracic trauma , previous thoracic surgery , antiplatelet routine treatment , anticoagulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>acute pericarditis</keyword>
	<keyword>treatment</keyword>
	<keyword>recurrence</keyword>
</DOC>